DICON in The Lancet

Dr. Deverick Anderson et al.'s study, the Benefits of Enhanced Terminal Room Disinfection, has been published in The Lancet. Click here to view a video by Dr. Anderson on the study, and see the "DICON News" section of our website for a link to the study abstract. 

Helping Hospitals Control Infections

DICON works with hospitals around the world to provide sophisticated data analysis and metrics, access to experts in infection control, opportunities to share successful programs, and extensive educational initiatives related to infection prevention.


DICON provides easy, immediate, and convenient access to nationally recognized physician-epidemiologists who assist hospitals in developing focused, practical strategies to prevent infections and reduce infection rates.

DICON Training Gets a New Site

The DICON training site has been upgraded to an all new powerful LMS system. The new system will allow us to easily add new courses and we will have several new courses coming on-line in the next six months.


BETR Disinfection Study Published in The Lancet

Dr. Deverick Anderson et al.'s study, the Benefits of Enhanced Terminal Room Disinfection (BETR-D), has been published in the journal The Lancet. The study investigates the role of enhanced disinfection of hospital rooms in preventing patient acquisition of drug-resistant pathogens. Study contributors include several other members of the DICON and DASON team, as well as faculty from the University of North Carolina at Chapel Hill, Duke's partner site in the CDC Prevention Epicenters Program. Click here for a link to the study abstract.

Read More

Deverick Anderson’s ASCOT trial featured in Forbes

Deverick Anderson MD, MPH was recently featured in an article about the Antimicrobial Scrub and Transmission (ASCOT) Trial, a study he was principal investigator on. The trial examined the “transmission triangle” in hospital settings: the patient, the healthcare provider, and the environment. Results showed that nurses in the intensive care unit were becoming contaminated with drug resistant infectious organisms such as MRSA and VRE not only from patients, but also from the hospital environment. The research re-emphasizes the importance of proper hand hygiene and clothing protection strategies as critical elements of an effective infection prevention strategy.

Read More

Duke awarded 4 year, $11 million grant from the CDC

DICON and DASON researchers were awarded an $11 million grant from the Centers for Disease Control and Prevention (CDC) to investigate antimicrobial resistance and sepsis prevention strategies. The grant, which supports the work of academic institutions in the CDC Prevention Epicenters Program, will fund several studies at Duke, as well as collaborative research projects with other program members, including Harvard University, Washington University in St. Louis and the University of Pennsylvania.

To learn more about the CDC Prevention Epicenters Program, visit http://www.cdc.gov/hai/epicenters/

Read More

During the past 18 years DICON has provided epidemiological data and support to more than 40 hospitals in 6 states while simultaneously learning a great deal about the challenges and opportunities for infection prevention in community hospitals.

—Dan Sexton, MD, Medical Director of DICON

DICON has been a long-term and valuable partner with my hospitals and me in our joint efforts to prevent hospital-acquired infections and improve patient safety.

—Conrad Schwab, MD, Chair of Infection Control, Chesapeake Regional Medical Center